Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Chronic Inflammatory Bowel Disease | Research

Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study

Authors: Timo M. Blomster, Olli-Pekka Koivurova, Ritva Koskela, Karl-Heinz Herzig, Nicholas J. Talley, Jukka Ronkainen

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

The pathogenesis of inflammatory bowel disease (IBD) has not been fully elucidated. The aim of this study was to analyze the pregnancy period, perinatal period, and infancy period risk factors for IBD in a well-characterized birth cohort from Northern Finland.

Methods

The Northern Finland Birth Cohort 1966 (NFBC1966) population comprises mothers living in the two northernmost provinces of Finland, Oulu, and Lapland, with dates of delivery between Jan 1st and Dec 31st, 1966 (12 055 mothers, 12 058 live-born children, 96.3% of all births during 1966). IBD patients were identified using hospital registries (from 1966 to 2020) and Social Insurance Institution (SII) registry reimbursement data for IBD drugs (from 1978 to 2016). The data were analyzed by Fisher’s exact test and logistic regression.

Results

In total, 6972 individuals provided informed consent for the use of combined SII and hospital registry data. Of those, 154 (2.1%) had IBD (113 [1.6%] had ulcerative colitis (UC), and 41 (0.6%) had Crohn’s disease (CD)). According to multivariate analysis, maternal smoking > 10 cigarettes/day during pregnancy was associated with a nearly 6-fold increased risk of CD in the offspring (OR 5.78, 95% CI 1.70–17.3). Breastfeeding (OR = 0.18, 95% CI 0.08–0.44) and iron supplementation during the first year of life (OR = 0.43, 95% CI 0.21–0.89) were negatively associated with CD.

Conclusions

Smoking during pregnancy was associated with the risk of CD while Breastfeeding and oral iron supplementation at infancy were negatively associated with the risk of CD later in life.
Literature
1.
go back to reference Olén O, Askling J, Sachs MC, et al. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964–2014. BMJ. 2017;358:j3951.PubMedPubMedCentralCrossRef Olén O, Askling J, Sachs MC, et al. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964–2014. BMJ. 2017;358:j3951.PubMedPubMedCentralCrossRef
3.
go back to reference Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–78.CrossRef Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–78.CrossRef
4.
go back to reference Burisch J, Jess T, Martinato M, Lakatos PL, EpiCom E. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–37.PubMedCrossRef Burisch J, Jess T, Martinato M, Lakatos PL, EpiCom E. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–37.PubMedCrossRef
5.
go back to reference Jussila A, Virta LJ, Kautiainen H, Rekiaro M, Nieminen U, Farkkila MA. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis. 2012;18(3):555–61.PubMedCrossRef Jussila A, Virta LJ, Kautiainen H, Rekiaro M, Nieminen U, Farkkila MA. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis. 2012;18(3):555–61.PubMedCrossRef
6.
go back to reference Moller FT, Andersen V, Wohlfahrt J, Jess T. Familial risk of inflammatory bowel disease: a population-based cohort study 1977–2011. Am J Gastroenterol. 2015;110(4):564–71.PubMedCrossRef Moller FT, Andersen V, Wohlfahrt J, Jess T. Familial risk of inflammatory bowel disease: a population-based cohort study 1977–2011. Am J Gastroenterol. 2015;110(4):564–71.PubMedCrossRef
7.
go back to reference Agrawal M, Burisch J, Colombel JF, Shah SC. Viewpoint: inflammatory bowel diseases among immigrants from low- to high-incidence countries: opportunities and considerations. J Crohns Colitis. 2020;14(2):267–73.PubMedCrossRef Agrawal M, Burisch J, Colombel JF, Shah SC. Viewpoint: inflammatory bowel diseases among immigrants from low- to high-incidence countries: opportunities and considerations. J Crohns Colitis. 2020;14(2):267–73.PubMedCrossRef
8.
go back to reference Roberts SE, Wotton CJ, Williams JG, Griffith M, Goldacre MJ. Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol. 2011;17(6):743–9.PubMedPubMedCentralCrossRef Roberts SE, Wotton CJ, Williams JG, Griffith M, Goldacre MJ. Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol. 2011;17(6):743–9.PubMedPubMedCentralCrossRef
9.
go back to reference Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther. 2017;46(10):911–9.PubMedCrossRef Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther. 2017;46(10):911–9.PubMedCrossRef
11.
go back to reference Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn’s disease. An international cooperative study. Scand J Gastroenterol. 1987;22(8):1009–24.PubMedCrossRef Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn’s disease. An international cooperative study. Scand J Gastroenterol. 1987;22(8):1009–24.PubMedCrossRef
12.
go back to reference Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54(3):357–63.PubMedPubMedCentralCrossRef Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54(3):357–63.PubMedPubMedCentralCrossRef
13.
go back to reference Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25(2):325–33.PubMedCrossRef Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25(2):325–33.PubMedCrossRef
14.
go back to reference Bernstein CN, Burchill C, Targownik LE, Singh H, Roos LL. Events within the First Year of Life, but not the neonatal period, affect risk for later development of Inflammatory Bowel diseases. Gastroenterology. 2019;156(8):2190–e21972110.PubMedCrossRef Bernstein CN, Burchill C, Targownik LE, Singh H, Roos LL. Events within the First Year of Life, but not the neonatal period, affect risk for later development of Inflammatory Bowel diseases. Gastroenterology. 2019;156(8):2190–e21972110.PubMedCrossRef
15.
go back to reference Sonntag B, Stolze B, Heinecke A, et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis. 2007;13(11):1385–90.PubMedCrossRef Sonntag B, Stolze B, Heinecke A, et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis. 2007;13(11):1385–90.PubMedCrossRef
16.
go back to reference Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780–9.PubMedPubMedCentralCrossRef Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780–9.PubMedPubMedCentralCrossRef
17.
go back to reference Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.PubMedCrossRef Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.PubMedCrossRef
18.
go back to reference Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12:51.PubMedPubMedCentralCrossRef Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12:51.PubMedPubMedCentralCrossRef
19.
go back to reference Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5(6):577–84.PubMedCrossRef Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5(6):577–84.PubMedCrossRef
20.
go back to reference Pineton de Chambrun G, Dauchet L, Gower-Rousseau C, Cortot A, Colombel JF, Peyrin-Biroulet L. Vaccination and risk for developing inflammatory bowel disease: a Meta-analysis of Case-Control and Cohort studies. Clin Gastroenterol Hepatol. 2015;13(8):1405–15. e1401; quiz e1130.PubMedCrossRef Pineton de Chambrun G, Dauchet L, Gower-Rousseau C, Cortot A, Colombel JF, Peyrin-Biroulet L. Vaccination and risk for developing inflammatory bowel disease: a Meta-analysis of Case-Control and Cohort studies. Clin Gastroenterol Hepatol. 2015;13(8):1405–15. e1401; quiz e1130.PubMedCrossRef
21.
go back to reference Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand. 1969;193(Suppl 193):191. Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand. 1969;193(Suppl 193):191.
22.
go back to reference von Wendt L, Mäkinen H, Rantakallio P. Psychomotor development in the first year and mental retardation–a prospective study. J Ment Defic Res. 1984;28(Pt 3):219–25. von Wendt L, Mäkinen H, Rantakallio P. Psychomotor development in the first year and mental retardation–a prospective study. J Ment Defic Res. 1984;28(Pt 3):219–25.
23.
go back to reference StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP [computer program]. StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP [computer program].
24.
go back to reference Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.PubMedCrossRef Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.PubMedCrossRef
25.
go back to reference Kuenzig ME, Lee SM, Eksteen B, et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016;16(1):143.PubMedPubMedCentralCrossRef Kuenzig ME, Lee SM, Eksteen B, et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016;16(1):143.PubMedPubMedCentralCrossRef
26.
go back to reference Aspberg S, Dahlquist G, Kahan T, Kallen B. Fetal and perinatal risk factors for inflammatory bowel disease. Acta Paediatr. 2006;95(8):1001–4.PubMedCrossRef Aspberg S, Dahlquist G, Kahan T, Kallen B. Fetal and perinatal risk factors for inflammatory bowel disease. Acta Paediatr. 2006;95(8):1001–4.PubMedCrossRef
27.
go back to reference Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol. 1993;88(3):356–9.PubMed Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol. 1993;88(3):356–9.PubMed
28.
go back to reference Russell RK, Farhadi R, Wilson M, Drummond H, Satsangi J, Wilson DC. Perinatal passive smoke exposure may be more important than childhood exposure in the risk of developing childhood IBD. Gut. 2005;54(10):1500–1. author reply 1501.PubMedPubMedCentral Russell RK, Farhadi R, Wilson M, Drummond H, Satsangi J, Wilson DC. Perinatal passive smoke exposure may be more important than childhood exposure in the risk of developing childhood IBD. Gut. 2005;54(10):1500–1. author reply 1501.PubMedPubMedCentral
29.
go back to reference Hammer T, Lophaven SN, Nielsen KR, et al. Dietary risk factors for inflammatory bowel diseases in a high-risk population: results from the faroese IBD study. United Eur Gastroenterol J. 2019;7(7):924–32.CrossRef Hammer T, Lophaven SN, Nielsen KR, et al. Dietary risk factors for inflammatory bowel diseases in a high-risk population: results from the faroese IBD study. United Eur Gastroenterol J. 2019;7(7):924–32.CrossRef
30.
go back to reference Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol. 2018;200(5):677–84.PubMedCrossRef Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol. 2018;200(5):677–84.PubMedCrossRef
31.
go back to reference Tapiainen T, Paalanne N, Tejesvi MV, et al. Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium. Pediatr Res. 2018;84(3):371–9.PubMedCrossRef Tapiainen T, Paalanne N, Tejesvi MV, et al. Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium. Pediatr Res. 2018;84(3):371–9.PubMedCrossRef
32.
go back to reference Wiklund P, Karhunen V, Richmond RC, et al. DNA methylation links prenatal smoking exposure to later life health outcomes in offspring. Clin Epigenetics. 2019;11(1):97.PubMedPubMedCentralCrossRef Wiklund P, Karhunen V, Richmond RC, et al. DNA methylation links prenatal smoking exposure to later life health outcomes in offspring. Clin Epigenetics. 2019;11(1):97.PubMedPubMedCentralCrossRef
33.
go back to reference Agrawal M, Sabino J, Frias-Gomes C, et al. Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses. EClinicalMedicine. 2021;36:100884.PubMedPubMedCentralCrossRef Agrawal M, Sabino J, Frias-Gomes C, et al. Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses. EClinicalMedicine. 2021;36:100884.PubMedPubMedCentralCrossRef
34.
go back to reference Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68(2):218–25.PubMedCrossRef Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68(2):218–25.PubMedCrossRef
35.
go back to reference Bernstein CN, Burchill C, Targownik LE, Singh H, Ghia JE, Roos LL. Maternal infections that would Warrant Antibiotic Use Antepartum or Peripartum are not a risk factor for the development of IBD: a Population-based analysis. Inflamm Bowel Dis. 2017;23(4):635–40.PubMedCrossRef Bernstein CN, Burchill C, Targownik LE, Singh H, Ghia JE, Roos LL. Maternal infections that would Warrant Antibiotic Use Antepartum or Peripartum are not a risk factor for the development of IBD: a Population-based analysis. Inflamm Bowel Dis. 2017;23(4):635–40.PubMedCrossRef
36.
go back to reference Otte JM, Kiehne K, Herzig KH. Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol. 2003;38(8):717–26.PubMedCrossRef Otte JM, Kiehne K, Herzig KH. Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol. 2003;38(8):717–26.PubMedCrossRef
37.
go back to reference Lee T, Clavel T, Smirnov K, et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017;66(5):863–71.PubMedCrossRef Lee T, Clavel T, Smirnov K, et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017;66(5):863–71.PubMedCrossRef
38.
go back to reference Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d’Ivoire. Am J Clin Nutr. 2010;92(6):1406–15.PubMedCrossRef Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d’Ivoire. Am J Clin Nutr. 2010;92(6):1406–15.PubMedCrossRef
39.
go back to reference Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731–42.PubMedCrossRef Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731–42.PubMedCrossRef
40.
go back to reference Rampton DS, Goodhand JR, Joshi NM, et al. Oral Iron treatment response and predictors in anaemic adolescents and adults with IBD: a prospective controlled open-label trial. J Crohns Colitis. 2017;11(6):706–15.PubMed Rampton DS, Goodhand JR, Joshi NM, et al. Oral Iron treatment response and predictors in anaemic adolescents and adults with IBD: a prospective controlled open-label trial. J Crohns Colitis. 2017;11(6):706–15.PubMed
41.
go back to reference Villumsen M, Jess T, Sørup S, et al. Risk of inflammatory bowel disease following Bacille Calmette-Guérin and smallpox vaccination: a population-based Danish case-cohort study. Inflamm Bowel Dis. 2013;19(8):1717–24.PubMedCrossRef Villumsen M, Jess T, Sørup S, et al. Risk of inflammatory bowel disease following Bacille Calmette-Guérin and smallpox vaccination: a population-based Danish case-cohort study. Inflamm Bowel Dis. 2013;19(8):1717–24.PubMedCrossRef
42.
go back to reference Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911–20.PubMedCrossRef Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911–20.PubMedCrossRef
43.
go back to reference Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–73.PubMedPubMedCentralCrossRef Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–73.PubMedPubMedCentralCrossRef
44.
go back to reference Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: a Slovak case-control study. United Eur Gastroenterol J. 2013;1(2):109–19.CrossRef Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: a Slovak case-control study. United Eur Gastroenterol J. 2013;1(2):109–19.CrossRef
45.
go back to reference Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel diseases: a systematic review and Meta-analysis. Inflamm Bowel Dis. 2016;22(9):2191–9.PubMedCrossRef Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel diseases: a systematic review and Meta-analysis. Inflamm Bowel Dis. 2016;22(9):2191–9.PubMedCrossRef
47.
go back to reference Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374:n1554.PubMedPubMedCentralCrossRef Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374:n1554.PubMedPubMedCentralCrossRef
48.
go back to reference Ponsonby AL, Catto-Smith AG, Pezic A, et al. Association between early-life factors and risk of child-onset Crohn’s disease among victorian children born 1983–1998: a birth cohort study. Inflamm Bowel Dis. 2009;15(6):858–66.PubMedCrossRef Ponsonby AL, Catto-Smith AG, Pezic A, et al. Association between early-life factors and risk of child-onset Crohn’s disease among victorian children born 1983–1998: a birth cohort study. Inflamm Bowel Dis. 2009;15(6):858–66.PubMedCrossRef
49.
go back to reference Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis. 2011;17(8):1778–83.PubMedCrossRef Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis. 2011;17(8):1778–83.PubMedCrossRef
50.
go back to reference Kontola K, Oksanen P, Huhtala H, et al. Increasing incidence of inflammatory bowel Disease, with Greatest Change among the Elderly: a Nationwide Study in Finland, 2000–2020. J Crohn Colitis. 2023;17(5):706–11.CrossRef Kontola K, Oksanen P, Huhtala H, et al. Increasing incidence of inflammatory bowel Disease, with Greatest Change among the Elderly: a Nationwide Study in Finland, 2000–2020. J Crohn Colitis. 2023;17(5):706–11.CrossRef
Metadata
Title
Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study
Authors
Timo M. Blomster
Olli-Pekka Koivurova
Ritva Koskela
Karl-Heinz Herzig
Nicholas J. Talley
Jukka Ronkainen
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18549-z

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue